Northwest Bio drug for inoperable tumors safe so far -researcher

June 19 (Reuters) - An experimental Northwest Therapeutics Inc drug for inoperable tumors has shown no signs of toxicity in an ongoing safety trial being conducted at M.D. Anderson Cancer Center, the trial's researcher said on Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.